ÂÜÀòÂÒÂ×

Ed Fiorentino is Chairman of the Board and CEO of TerSera Therapeutics. Previously, Ed was Chairman of the Board and CEO of specialty pharmaceutical company Crealta Pharmaceuticals, and CEO of Actient Pharmaceuticals.

Prior to Crealta and Actient, Ed was with Abbott for more than 20 years. His senior-level management experience at Abbott includes Corporate Vice President of pharmaceutical commercial operations; Senior Vice President and President of Abbott Diabetes Care; and Executive Vice President of TAP Pharmaceuticals, an Abbott joint venture with Takeda Pharmaceuticals. Ed began his career with Bristol-Myers.

Ed currently serves on the boards of TerSera Therapeutics, Senseonics, and Clearbrook. He previously served on the boards of Crealta Pharmaceuticals, Actient Pharmaceuticals, TAP Pharmaceuticals, Graceway Pharmaceuticals, iBIO, California Healthcare Institute, National Pharmaceutical Council, and Allendale Association. Ed holds a B.S. in Business Administration from the State University of New York and an M.B.A. from Syracuse University.